Abraham Avigdor Selected Research

Immunotherapy

4/2024	[CHIMERIC ANTIGEN RECEPTOR T CELLS (CAR-T CELLS) THERAPY FOR B-CELL HEMATOLOGICAL MALIGNANCIES - FROM THE ISRAELI SOCIETY OF HEMATOLOGY AND TRANSFUSION MEDICINE].
1/2022	Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell Malignancies.
1/2020	Treatment with anti CD19 chimeric antigen receptor T cells after antibody-based immunotherapy in adults with acute lymphoblastic leukemia.
3/2015	Salvage therapy with ARA-C and gemtuzumab ozogamicin in AML patients relapsing after stem cell transplantation.
1/2015	Anti-PD-1-targeted therapies focusing on lymphatic malignancies: biological rationale, clinical challenges and opportunities.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Abraham Avigdor Research Topics

Disease

14	Neoplasms (Cancer) 04/2024 - 10/2003
13	Lymphoma (Lymphomas) 12/2023 - 04/2002
13	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2023 - 01/2003
10	B-Cell Lymphoma (Lymphoma, B Cell) 12/2023 - 01/2008
8	Multiple Myeloma 10/2023 - 09/2014
6	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 04/2024 - 01/2008
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2024 - 10/2003
6	Leukemia 01/2022 - 01/2003
5	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2024 - 02/2016
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2020 - 08/2003
4	Hodgkin Disease (Hodgkin's Disease) 05/2022 - 04/2008
4	Neutropenia 10/2019 - 08/2003
3	Hematologic Neoplasms (Hematological Malignancy) 04/2024 - 05/2003
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 09/2023 - 11/2020
3	Disease Progression 12/2022 - 02/2016
3	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 08/2003
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 04/2024 - 11/2014
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 07/2023 - 01/2019
2	Thrombocytopenia (Thrombopenia) 02/2016 - 03/2015
1	COVID-19 03/2024
1	Pneumonia (Pneumonitis) 10/2023
1	cell-associated neurotoxicity 08/2023
1	Thrombosis (Thrombus) 05/2023
1	Injection Site Reaction 01/2023
1	Headache (Headaches) 01/2023
1	Fatigue 01/2023
1	Cardiotoxicity 02/2021
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Proteinuria 01/2021
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 12/2019
1	T-Cell Lymphoma (Lymphoma, T Cell) 12/2019
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 12/2019
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2019
1	Pathologic Complete Response 10/2018
1	Inflammation (Inflammations) 04/2016

Drug/Important Bio-Agent (IBA)

13	Chimeric Antigen ReceptorsIBA 04/2024 - 12/2018
7	Rituximab (Mabthera)FDA Link 12/2020 - 08/2003
4	Proteins (Proteins, Gene)FDA Link 10/2023 - 10/2003
4	Bortezomib (Velcade)FDA Link 12/2020 - 09/2014
4	Bendamustine Hydrochloride FDA Link 12/2020 - 01/2016
4	Dexamethasone (Maxidex)FDA LinkGeneric 12/2020 - 09/2014
3	Monoclonal AntibodiesIBA 03/2024 - 01/2017
3	AnthracyclinesIBA 02/2021 - 01/2008
3	ibrutinibIBA 12/2020 - 02/2016
3	Deoxyglucose (2 Deoxy D glucose)IBA 08/2014 - 04/2008
3	Dual Specificity Phosphatase 1IBA 10/2003 - 01/2003
2	Agammaglobulinaemia Tyrosine KinaseIBA 02/2024 - 02/2016
2	parsaclisibIBA 12/2023 - 09/2023
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023 - 04/2022
2	Messenger RNA (mRNA)IBA 01/2022 - 10/2003
2	STK405759IBA 07/2018 - 01/2016
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2015 - 09/2014
2	Thalidomide (Thalomid)FDA Link 02/2015 - 09/2014
2	FluorineIBA 11/2014 - 08/2014
2	ibritumomab tiuxetan (Zevalin)FDA Link 10/2012 - 04/2007
1	AntigensIBA 04/2024
1	tixagevimabIBA 03/2024
1	cilgavimabIBA 03/2024
1	venetoclaxIBA 10/2023
1	TroponinIBA 10/2023
1	CytokinesIBA 08/2023
1	midostaurinIBA 01/2023
1	tisagenlecleucelIBA 12/2022
1	Immunoglobulins (Immunoglobulin)IBA 10/2022
1	Pyridinolcarbamate (P23)IBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Brentuximab VedotinIBA 12/2021
1	bisantreneIBA 02/2021
1	anthraceneIBA 02/2021
1	polatuzumab vedotinIBA 01/2021
1	selinexorIBA 12/2020
1	Cytarabine (Cytosar-U)FDA LinkGeneric 06/2020
1	Mitoxantrone (Novantrone)FDA LinkGeneric 06/2020
1	romidepsin (FK228)FDA Link 12/2019
1	Histone Deacetylases (Histone Deacetylase)IBA 12/2019
1	Histone Deacetylase InhibitorsIBA 12/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	Gemcitabine FDA Link 01/2019
1	Vinblastine (Vinblastine Sulfate)FDA Link 10/2018
1	Vincristine (Oncovin)FDA LinkGeneric 10/2018
1	Dacarbazine (DIC)FDA LinkGeneric 10/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2018
1	Angiogenesis InhibitorsIBA 07/2018
1	Cytotoxins (Cytolysins)IBA 07/2018
1	Thrombin FDA Link 01/2017
1	Immunomodulating AgentsIBA 01/2017
1	Immune Checkpoint InhibitorsIBA 01/2017
1	Programmed Cell Death 1 ReceptorIBA 01/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2016

Therapy/Procedure

31	Therapeutics 04/2024 - 04/2002
15	Drug Therapy (Chemotherapy) 05/2023 - 08/2003
6	Stem Cell Transplantation 12/2021 - 08/2003
5	Immunotherapy 04/2024 - 01/2015
3	Induction Chemotherapy 10/2023 - 01/2022
3	Salvage Therapy 07/2023 - 01/2019
2	Hematopoietic Stem Cell Transplantation 07/2023 - 01/2020
2	Transplantation 07/2023 - 01/2022
1	Cell Transplantation 01/2023
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022
1	Radiotherapy 10/2018